Signature Wealth Management Partners’s Boston Scientific BSX Stock Holding History

Signature Wealth Management Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,956	Closed	-$508K	–	115
2021 Q4	$508K	Hold	11,956	–	–	0.43%	58
2021 Q3	$519K	Hold	11,956	–	–	0.47%	55
2021 Q2	$511K	Hold	11,956	–	–	0.46%	55
2021 Q1	$462K	Buy	11,956 +3,250	+37%	+$123K	0.44%	60
2020 Q4	$313K	Buy	+8,706	New	+$314K	0.31%	67

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Signature Wealth Management Partners's BSX Position: Q1 2022 in Review

Signature Wealth Management Partners sold out of Boston Scientific (BSX) in Q1 2022, closing a stake of 11,956 shares — an estimated $508K sold.

Signature Wealth Management Partners first reported a position in BSX in Q4 2020 and held it in 5 quarters. The position peaked at $519K in Q3 2021. 904 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

Signature Wealth Management Partners reported no remaining Boston Scientific position as of Q1 2022 after selling out during the quarter.
Signature Wealth Management Partners sold 11,956 Boston Scientific shares in Q1 2022, an estimated $508K.
Signature Wealth Management Partners first reported a position in Boston Scientific in Q4 2020 and held it in 5 quarters.
Signature Wealth Management Partners's Boston Scientific position peaked at $519K in Q3 2021.
904 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Signature Wealth Management Partners's 13F filing for Q1 2022, filed 10 May 2022.